BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jarosz-Biej M, Smolarczyk R, Cichoń T, Kułach N. Tumor Microenvironment as A "Game Changer" in Cancer Radiotherapy. Int J Mol Sci 2019;20:E3212. [PMID: 31261963 DOI: 10.3390/ijms20133212] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 22.7] [Reference Citation Analysis]
Number Citing Articles
1 Ristescu AI, Tiron CE, Tiron A, Grigoras I. Exploring Hyperoxia Effects in Cancer-From Perioperative Clinical Data to Potential Molecular Mechanisms. Biomedicines 2021;9:1213. [PMID: 34572400 DOI: 10.3390/biomedicines9091213] [Reference Citation Analysis]
2 Wang Q, Li S, Qiao S, Zheng Z, Duan X, Zhu X. Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis. Front Immunol 2021;12:648652. [PMID: 34220806 DOI: 10.3389/fimmu.2021.648652] [Reference Citation Analysis]
3 Qiu H, Ke S, Cai G, Wu Y, Wang J, Shi W, Chen J, Peng J, Yu B, Chen Y. An exploratory clinical trial of apatinib combined with intensity-modulated radiation therapy for patients with unresectable hepatocellular carcinoma. Cancer Med 2022. [PMID: 35633045 DOI: 10.1002/cam4.4900] [Reference Citation Analysis]
4 Mäurer M, Pachmann K, Wendt T, Schott D, Wittig A. Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients. Curr Oncol 2021;28:3507-24. [PMID: 34590615 DOI: 10.3390/curroncol28050302] [Reference Citation Analysis]
5 Tanuma SI, Oyama T, Okazawa M, Yamazaki H, Takao K, Sugita Y, Amano S, Abe T, Sakagami H. A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling. Int J Mol Sci 2022;23:3426. [PMID: 35408786 DOI: 10.3390/ijms23073426] [Reference Citation Analysis]
6 Zhang J, Jiang D, Lyu M, Ren S, Zhou Y, Cao Z. Synergistic Radiosensitization Mediated by Chemodynamic Therapy via a Novel Biodegradable Peroxidases Mimicking Nanohybrid. Front Oncol 2022;12:872502. [PMID: 35619898 DOI: 10.3389/fonc.2022.872502] [Reference Citation Analysis]
7 Mireştean CC, Crişan A, Buzea C, Iancu RI, Iancu DT. Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes-"Immunological Dose Painting". Medicina (Kaunas) 2020;57:6. [PMID: 33374739 DOI: 10.3390/medicina57010006] [Reference Citation Analysis]
8 Olivares-Urbano MA, Griñán-Lisón C, Marchal JA, Núñez MI. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer. Cells 2020;9:E1651. [PMID: 32660072 DOI: 10.3390/cells9071651] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
9 Beauford SS, Kumari A, Garnett-Benson C. Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells. BMC Immunol 2020;21:18. [PMID: 32299365 DOI: 10.1186/s12865-020-00349-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 de Faria FP, Petroianu A, Mota LG, Fernandes SOA, Geraldo JM, Nascimento CB, Vital KD. Splenic, hepatic, renal and pulmonary clearance dysfunction associated with high-energy X-rays. Int J Radiat Biol 2022;:1-4. [PMID: 34919028 DOI: 10.1080/09553002.2022.2020360] [Reference Citation Analysis]
11 Pei P, Liu T, Shen W, Liu Z, Yang K. Biomaterial-mediated internal radioisotope therapy. Mater Horiz 2021;8:1348-66. [DOI: 10.1039/d0mh01761b] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang J, Shi W, Miao Y, Gan J, Guan Q, Ran J. Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13. Bioengineered 2021;12:6286-304. [PMID: 34494914 DOI: 10.1080/21655979.2021.1971029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 León X, García J, Farré N, Majercakova K, Avilés-Jurado FX, Quer M, Camacho M. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy. Acta Otorrinolaringol Esp (Engl Ed) 2021;72:337-43. [PMID: 34844671 DOI: 10.1016/j.otoeng.2020.05.006] [Reference Citation Analysis]
14 Smolarczyk R, Czapla J, Jarosz-Biej M, Czerwinski K, Cichoń T. Vascular disrupting agents in cancer therapy. Eur J Pharmacol 2021;891:173692. [PMID: 33130277 DOI: 10.1016/j.ejphar.2020.173692] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Yu S, Wang Y, He P, Shao B, Liu F, Xiang Z, Yang T, Zeng Y, He T, Ma J, Wang X, Liu L. Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment. Front Oncol 2022;12:809304. [DOI: 10.3389/fonc.2022.809304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 De Michino S, Aparnathi M, Rostami A, Lok BH, Bratman SV. The Utility of Liquid Biopsies in Radiation Oncology. Int J Radiat Oncol Biol Phys 2020;107:873-86. [PMID: 32417410 DOI: 10.1016/j.ijrobp.2020.05.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Li R, Che W, Liang N, Deng S, Song Z, Yang L. Silent FOSL1 Enhances the Radiosensitivity of Glioma Stem Cells by Down-Regulating miR-27a-5p. Neurochem Res 2021;46:3222-46. [PMID: 34420141 DOI: 10.1007/s11064-021-03427-6] [Reference Citation Analysis]
18 Shi Y, Liu M, Wu H, Han Y, He X, Shi Z. GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer. Disease Markers 2022;2022:1-14. [DOI: 10.1155/2022/9109365] [Reference Citation Analysis]
19 Hao X, Wu J, Xiang D, Yang Y. Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years. Front Pharmacol 2022;13:846715. [DOI: 10.3389/fphar.2022.846715] [Reference Citation Analysis]
20 Yang L, Zeng L, Hong G, Luo Q, Lai X, Wang F. Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/6535009] [Reference Citation Analysis]
21 Barillari G, Bei R, Manzari V, Modesti A. Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events? Int J Mol Sci 2021;22:13543. [PMID: 34948338 DOI: 10.3390/ijms222413543] [Reference Citation Analysis]
22 Cochran HC, Pandey Y, Nicholas RW, Del Giacco EJ, Mazin Safar A. Immune oncology (IO) and metastatic lung cancer [CBD]: Curability, bony metastasis and duration of therapy. Current Problems in Cancer: Case Reports 2021;4:100129. [DOI: 10.1016/j.cpccr.2021.100129] [Reference Citation Analysis]
23 Okubo S, Suzuki T, Hioki M, Shimizu Y, Toyama H, Morinaga S, Gotohda N, Uesaka K, Ishii G, Takahashi S, Kojima M. The immunological impact of preoperative chemoradiotherapy on the tumor microenvironment of pancreatic cancer. Cancer Sci 2021;112:2895-904. [PMID: 33931909 DOI: 10.1111/cas.14914] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Feng Y, Wang Z, Yang N, Liu S, Yan J, Song J, Yang S, Zhang Y. Identification of Biomarkers for Cervical Cancer Radiotherapy Resistance Based on RNA Sequencing Data. Front Cell Dev Biol 2021;9:724172. [PMID: 34414195 DOI: 10.3389/fcell.2021.724172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Si C, Chen C, Guo Y, Kang Q, Sun Z. Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment. Front Cell Dev Biol 2021;9:711815. [PMID: 34660577 DOI: 10.3389/fcell.2021.711815] [Reference Citation Analysis]
26 Molenaar-Kuijsten L, van Meekeren M, Verheijen RB, Bovée JVMG, Fiocco M, Thijssen B, Rosing H, Huitema ADR, Miah AB, Gelderblom H, Haas RLM, Steeghs N. Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma. Cancers (Basel) 2021;13:5780. [PMID: 34830931 DOI: 10.3390/cancers13225780] [Reference Citation Analysis]
27 Li J, Xie J, Wu D, Chen L, Gong Z, Wu R, Hu Y, Zhao J, Xu Y. A pan-cancer analysis revealed the role of the SLC16 family in cancer. Channels (Austin) 2021;15:528-40. [PMID: 34424811 DOI: 10.1080/19336950.2021.1965422] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Xu M, Wang P, Sun S, Gao L, Sun L, Zhang L, Zhang J, Wang S, Liang X. Smart strategies to overcome tumor hypoxia toward the enhancement of cancer therapy. Nanoscale 2020;12:21519-33. [DOI: 10.1039/d0nr05501h] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Ma X, Lee C, Zhang T, Cai J, Wang H, Jiang F, Wu Z, Xie J, Jiang G, Li Z. Image-guided selection of Gd@C-dots as sensitizers to improve radiotherapy of non-small cell lung cancer. J Nanobiotechnology 2021;19:284. [PMID: 34551763 DOI: 10.1186/s12951-021-01018-9] [Reference Citation Analysis]
30 Chen Y, Gao M, Huang Z, Yu J, Meng X. SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges. J Hematol Oncol 2020;13:105. [PMID: 32723363 DOI: 10.1186/s13045-020-00940-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Yang K, Choi C, Cho H, Ahn WG, Kim SY, Shin SW, Kim Y, Jang T, Lee N, Park HC. Antigen-Capturing Mesoporous Silica Nanoparticles Enhance the Radiation-Induced Abscopal Effect in Murine Hepatocellular Carcinoma Hepa1-6 Models. Pharmaceutics 2021;13:1811. [PMID: 34834226 DOI: 10.3390/pharmaceutics13111811] [Reference Citation Analysis]
32 Jafari R, Rahbarghazi R, Ahmadi M, Hassanpour M, Rezaie J. Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications. J Transl Med 2020;18:474. [PMID: 33302971 DOI: 10.1186/s12967-020-02662-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Wang X, Zhong L, Zhao Y. Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment (Review). Oncol Rep 2021;45:49. [PMID: 33760203 DOI: 10.3892/or.2021.8000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Mezheyeuski A, Micke P, Martín-Bernabé A, Backman M, Hrynchyk I, Hammarström K, Ström S, Ekström J, Edqvist PH, Sundström M, Ponten F, Leandersson K, Glimelius B, Sjöblom T. The Immune Landscape of Colorectal Cancer. Cancers (Basel) 2021;13:5545. [PMID: 34771707 DOI: 10.3390/cancers13215545] [Reference Citation Analysis]
35 Yang Y, Ren S, Huang W, Dong J, Guo J, Zhao J, Zhang Y. Camptothecin Delivery via Tumor-Derived Exosome for Radiosensitization by Cell Cycle Regulation on Patient-Derived Xenograft Mice. Front Bioeng Biotechnol 2022;10:876641. [DOI: 10.3389/fbioe.2022.876641] [Reference Citation Analysis]
36 Pinarbasi-degirmenci N, Sur-erdem I, Akcay V, Bolukbasi Y, Selek U, Solaroglu I, Bagci-onder T. Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia. IJMS 2022;23:7051. [DOI: 10.3390/ijms23137051] [Reference Citation Analysis]
37 Yu Y, Fu P, Jin JY, Gao S, Wang W, Machtay M, Wang L, Kong FS, Yu J. Impact of effective dose to immune cells (EDIC) on lymphocyte nadir and survival in limited-stage SCLC. Radiother Oncol 2021;162:26-33. [PMID: 34139210 DOI: 10.1016/j.radonc.2021.06.020] [Reference Citation Analysis]
38 D’andrea MA, Reddy GK. Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy. American Journal of Clinical Oncology 2020;43:218-28. [DOI: 10.1097/coc.0000000000000651] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Wang Y. Advances in Hypofractionated Irradiation-Induced Immunosuppression of Tumor Microenvironment. Front Immunol 2020;11:612072. [PMID: 33569059 DOI: 10.3389/fimmu.2020.612072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Arnold CR, Mangesius J, Skvortsova II, Ganswindt U. The Role of Cancer Stem Cells in Radiation Resistance. Front Oncol. 2020;10:164. [PMID: 32154167 DOI: 10.3389/fonc.2020.00164] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
41 Zhang C, Liang Z, Ma S, Liu X. Radiotherapy and Cytokine Storm: Risk and Mechanism. Front Oncol 2021;11:670464. [PMID: 34094967 DOI: 10.3389/fonc.2021.670464] [Reference Citation Analysis]
42 Lei L, Ma B, Xu C, Liu H. Emerging Tumor-on-Chips with Electrochemical Biosensors. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116640] [Reference Citation Analysis]
43 Zhang R, Kang J, Ren S, Xing L, Xu Y. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis. Ann Transl Med 2022;10:104. [PMID: 35282118 DOI: 10.21037/atm-21-6256] [Reference Citation Analysis]
44 Chen YA, Lai YR, Wu HY, Lo YJ, Chang YF, Hung CL, Lin CJ, Lo UG, Lin H, Hsieh JT, Chiu CH, Lin YH, Lai CH. Bacterial Genotoxin-Coated Nanoparticles for Radiotherapy Sensitization in Prostate Cancer. Biomedicines 2021;9:151. [PMID: 33557143 DOI: 10.3390/biomedicines9020151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Song J, Yi X, Gao R, Sun L, Wu Z, Zhang S, Huang L, Han C, Ma J. Impact of Drp1-Mediated Mitochondrial Dynamics on T Cell Immune Modulation. Front Immunol 2022;13:873834. [PMID: 35432303 DOI: 10.3389/fimmu.2022.873834] [Reference Citation Analysis]
46 Ji H, Zhou Z. A ‘Hybrid’ Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy. Cancers 2022;14:3505. [DOI: 10.3390/cancers14143505] [Reference Citation Analysis]
47 Wen P, Gao Y, Chen B, Qi X, Hu G, Xu A, Xia J, Wu L, Lu H, Zhao G. Pan-Cancer Analysis of Radiotherapy Benefits and Immune Infiltration in Multiple Human Cancers. Cancers (Basel) 2020;12:E957. [PMID: 32294976 DOI: 10.3390/cancers12040957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
48 Pastò A, Consonni FM, Sica A. Influence of Innate Immunity on Cancer Cell Stemness. Int J Mol Sci 2020;21:E3352. [PMID: 32397392 DOI: 10.3390/ijms21093352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
49 Brett E, Rosemann M, Azimzadeh O, Pagani A, Prahm C, Daigeler A, Duscher D, Kolbenschlag J. Irradiated Triple-Negative Breast Cancer Co-Culture Produces a Less Oncogenic Extracellular Matrix. Int J Mol Sci 2022;23:8265. [PMID: 35897841 DOI: 10.3390/ijms23158265] [Reference Citation Analysis]
50 Kim S, Yeo MK, Kim JS, Kim JY, Kim KH. Elevated CXCL12 in the plasma membrane of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a potential prognostic marker. J Cancer 2022;13:162-73. [PMID: 34976180 DOI: 10.7150/jca.64082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Shi Q, Yan X, Wang J, Zhang X. Collagen Family Genes Associated with Risk of Recurrence after Radiation Therapy for Vestibular Schwannoma and Pan-Cancer Analysis. Dis Markers 2021;2021:7897994. [PMID: 34691289 DOI: 10.1155/2021/7897994] [Reference Citation Analysis]
52 Ma X, Yao M, Gao Y, Yue Y, Li Y, Zhang T, Nie G, Zhao X, Liang X. Functional Immune Cell-Derived Exosomes Engineered for the Trilogy of Radiotherapy Sensitization. Adv Sci (Weinh) 2022;:e2106031. [PMID: 35715382 DOI: 10.1002/advs.202106031] [Reference Citation Analysis]
53 Yuan Y, Jiang X, Tang L, Wang J, Zhang D, Cho WC, Duan L. FOXM1/lncRNA TYMSOS/miR-214-3p–Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non–Small Cell Lung Carcinoma. Front Mol Biosci 2022;8:785767. [DOI: 10.3389/fmolb.2021.785767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
54 Zhu Q, Yuan J, He Y, Hu Y. The Effect of miR-520b on Macrophage Polarization and T Cell Immunity by Targeting PTEN in Breast Cancer. J Oncol 2021;2021:5170496. [PMID: 34659411 DOI: 10.1155/2021/5170496] [Reference Citation Analysis]
55 Liu J, Hong M, Li Y, Chen D, Wu Y, Hu Y. Programmed Cell Death Tunes Tumor Immunity. Front Immunol 2022;13:847345. [PMID: 35432318 DOI: 10.3389/fimmu.2022.847345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lumniczky K, Impens N, Armengol G, Candéias S, Georgakilas AG, Hornhardt S, Martin OA, Rödel F, Schaue D. Low dose ionizing radiation effects on the immune system. Environ Int 2021;149:106212. [PMID: 33293042 DOI: 10.1016/j.envint.2020.106212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
57 Park M, Kwon J, Kong J, Moon SM, Cho S, Yang KY, Jang WI, Kim MS, Kim Y, Shin US. A Patient-Derived Organoid-Based Radiosensitivity Model for the Prediction of Radiation Responses in Patients with Rectal Cancer. Cancers (Basel) 2021;13:3760. [PMID: 34359661 DOI: 10.3390/cancers13153760] [Reference Citation Analysis]
58 Pang J, Pan H, Yang C, Meng P, Xie W, Li J, Li Y, Xiao SY. Prognostic Value of Immune-Related Multi-IncRNA Signatures Associated With Tumor Microenvironment in Esophageal Cancer. Front Genet 2021;12:722601. [PMID: 34659345 DOI: 10.3389/fgene.2021.722601] [Reference Citation Analysis]
59 Sengedorj A, Hader M, Frey B, Fietkau R, Ott OJ, Gaipl US, Rückert M. Interaction of Radiotherapy and Hyperthermia with the Immune System: a Brief Current Overview. Curr Stem Cell Rep. [DOI: 10.1007/s40778-022-00215-y] [Reference Citation Analysis]
60 van Luijk IF, Smith SM, Marte Ojeda MC, Oei AL, Kenter GG, Jordanova ES. A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment. J Clin Med 2022;11:2277. [PMID: 35566403 DOI: 10.3390/jcm11092277] [Reference Citation Analysis]
61 Xu P, Zhang Y, Ge F, Zhang F, He X, Gao X. Modulation of Tumor Microenvironment to Enhance Radiotherapy Efficacy in Esophageal Squamous Cell Carcinoma by Inhibiting Carbonic Anhydrase IX. Front Oncol 2021;11:637252. [PMID: 34249682 DOI: 10.3389/fonc.2021.637252] [Reference Citation Analysis]
62 Zhong J, Chen J, Oyekan AA, Epperly MW, Greenberger JS, Lee JY, Sowa GA, Vo NV. Ionizing Radiation Induces Disc Annulus Fibrosus Senescence and Matrix Catabolism via MMP-Mediated Pathways. Int J Mol Sci 2022;23:4014. [PMID: 35409374 DOI: 10.3390/ijms23074014] [Reference Citation Analysis]
63 Tian Y, Sang W, Tian H, Xie L, Wang G, Zhang Z, Li W, Dai Y. A Two‐Step Flexible Ultrasound Strategy to Enhance the Tumor Radiotherapy via Metal–Phenolic Network Nanoplatform. Adv Funct Materials. [DOI: 10.1002/adfm.202205690] [Reference Citation Analysis]
64 Kool R, Marcq G, Shinde-jadhav S, Mansure JJ, Saleh R, Rajan R, Aprikian A, Tanguay S, Cury FL, Brimo F, Souhami L, Kassouf W. Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy. European Urology Open Science 2022;36:26-33. [DOI: 10.1016/j.euros.2021.11.011] [Reference Citation Analysis]
65 Du Z, Cai S, Yan D, Li H, Zhang X, Yang W, Cao J, Yi N, Tang Z. Development and Validation of a Radiosensitivity Prediction Model for Lower Grade Glioma Based on Spike-and-Slab Lasso. Front Oncol 2021;11:701500. [PMID: 34395274 DOI: 10.3389/fonc.2021.701500] [Reference Citation Analysis]
66 Pan S, Gao Q, Chen Q, Liu P, Tan Y, Liu F, Xu H. Integrative analysis-based identification and validation of a prognostic immune cell infiltration-based model for patients with advanced gastric cancer. Int Immunopharmacol 2021;101:108258. [PMID: 34678693 DOI: 10.1016/j.intimp.2021.108258] [Reference Citation Analysis]
67 Chen C, Chan Y, Lin S, Chiang HK, Lee Y, Chuang H. Theranostic Radiolabeled Nanomaterials for Molecular Imaging and potential Immunomodulation Effects. J Med Biol Eng . [DOI: 10.1007/s40846-022-00715-6] [Reference Citation Analysis]
68 Fukushima H, Yoshida S, Kijima T, Nakamura Y, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma. Int J Mol Sci 2021;22:E535. [PMID: 33430352 DOI: 10.3390/ijms22020535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Huang X, Zhang F, Wang X, Liu K. The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment. Cancers (Basel) 2022;14:2756. [PMID: 35681736 DOI: 10.3390/cancers14112756] [Reference Citation Analysis]
70 Guo D, Zheng K. Effect of Prophylactic Radiotherapy on Patients with Stage II-III Esophageal Cancer after Esophageal Cancer Radical Operation and Influencing Factors in Its Recurrence. J Oncol 2021;2021:7462012. [PMID: 34462636 DOI: 10.1155/2021/7462012] [Reference Citation Analysis]
71 Drzyzga A, Cichoń T, Czapla J, Jarosz-Biej M, Pilny E, Matuszczak S, Wojcieszek P, Urbaś Z, Smolarczyk R. The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers (Basel) 2021;13:3924. [PMID: 34439079 DOI: 10.3390/cancers13163924] [Reference Citation Analysis]
72 Xu X, Chen D, Feng X, Hu J, Ge J, Yan C, Zhang D, Ling Z, Chen J, Wu J. Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma. Front Oncol 2021;11:654689. [PMID: 33954113 DOI: 10.3389/fonc.2021.654689] [Reference Citation Analysis]
73 Poon DJJ, Tay LM, Ho D, Chua MLK, Chow EK, Yeo ELL. Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery. Cancer Lett 2021;511:56-67. [PMID: 33933554 DOI: 10.1016/j.canlet.2021.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
74 Ai D, Dou Y, Nan Z, Wang K, Wang H, Zhang L, Dong Z, Sun J, Ma C, Tan W, Gao W, Liu J, Zhao L, Liu S, Song B, Shao Q, Qu X. CD68+ Macrophage Infiltration Associates With Poor Outcome of HPV Negative Oral Squamous Carcinoma Patients Receiving Radiation: Poly(I:C) Enhances Radiosensitivity of CAL-27 Cells but Promotes Macrophage Recruitment Through HMGB1. Front Oncol 2021;11:740622. [PMID: 34568076 DOI: 10.3389/fonc.2021.740622] [Reference Citation Analysis]
75 Chua KLM, Chu PL, Tng DJH, Soo KC, Chua MLK. Repurposing Proton Beam Therapy through Novel Insights into Tumour Radioresistance. Clin Oncol (R Coll Radiol) 2021;33:e469-81. [PMID: 34509347 DOI: 10.1016/j.clon.2021.08.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Kronemberger GS, Miranda GASC, Tavares RSN, Montenegro B, Kopke ÚA, Baptista LS. Recapitulating Tumorigenesis in vitro: Opportunities and Challenges of 3D Bioprinting. Front Bioeng Biotechnol 2021;9:682498. [PMID: 34239860 DOI: 10.3389/fbioe.2021.682498] [Reference Citation Analysis]
77 de Faria FP, Petroianu A, Campos PP, de Lazari MGT, Geraldo JM, Nascimento CB, Siqueira SL. Changes in splenic uptake pattern associated with X-ray irradiation. Heliyon 2020;6:e04932. [PMID: 32995620 DOI: 10.1016/j.heliyon.2020.e04932] [Reference Citation Analysis]
78 Gong Y, Deng J, Wu X. Germline mutations and blood malignancy (Review). Oncol Rep 2021;45:49-57. [PMID: 33200226 DOI: 10.3892/or.2020.7846] [Reference Citation Analysis]
79 Liao Y, Liu S, Fu S, Wu J. HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity. Onco Targets Ther 2020;13:6859-71. [PMID: 32764978 DOI: 10.2147/OTT.S253772] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
80 Song J, Zhang S, Sun Y, Gu J, Ye Z, Sun X, Tang Q. A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer. J Oncol 2021;2021:4338838. [PMID: 34594376 DOI: 10.1155/2021/4338838] [Reference Citation Analysis]
81 Bertho A, Dos Santos M, François A, Milliat F. Radiobiologie des très fortes doses par fraction : connaissances en 2020 et nouvelles modélisations précliniques. Radioprotection 2021;56:11-24. [DOI: 10.1051/radiopro/2020072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
82 Tan S, Xia L, Yi P, Han Y, Tang L, Pan Q, Tian Y, Rao S, Oyang L, Liang J, Lin J, Su M, Shi Y, Cao D, Zhou Y, Liao Q. Exosomal miRNAs in tumor microenvironment. J Exp Clin Cancer Res. 2020;39:67. [PMID: 32299469 DOI: 10.1186/s13046-020-01570-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
83 Helfen A, Schnepel A, Rieß J, Stölting M, Gerwing M, Masthoff M, Vogl T, Roth J, Höltke C, Wildgruber M, Eisenblätter M. S100A9-Imaging Enables Estimation of Early Therapy-Mediated Changes in the Inflammatory Tumor Microenvironment. Biomedicines 2021;9:29. [PMID: 33401528 DOI: 10.3390/biomedicines9010029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Shu Y, Cheng P. Targeting tumor-associated macrophages for cancer immunotherapy. Biochim Biophys Acta Rev Cancer 2020;1874:188434. [PMID: 32956767 DOI: 10.1016/j.bbcan.2020.188434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 Wang Y, Jia A, Bi Y, Wang Y, Yang Q, Cao Y, Li Y, Liu G. Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy. Cancers (Basel) 2020;12:E2626. [PMID: 32942545 DOI: 10.3390/cancers12092626] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
86 Song H, Kim K, Han JM, Park WY, Seo HS, Lim S, Byun E. Ionizing radiation technology to improve the physicochemical and biological properties of natural compounds by molecular modification: A review. Radiation Physics and Chemistry 2022;194:110013. [DOI: 10.1016/j.radphyschem.2022.110013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 van Schaik TA, Chen KS, Shah K. Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy? Front Oncol 2021;11:678562. [PMID: 34141622 DOI: 10.3389/fonc.2021.678562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Li D, Stovall DB, Wang W, Sui G. Advances of Zinc Signaling Studies in Prostate Cancer. Int J Mol Sci 2020;21:E667. [PMID: 31963946 DOI: 10.3390/ijms21020667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
89 Wang X, Sun C, Huang X, Li J, Fu Z, Li W, Yin Y. The Advancing Roles of Exosomes in Breast Cancer. Front Cell Dev Biol 2021;9:731062. [PMID: 34790660 DOI: 10.3389/fcell.2021.731062] [Reference Citation Analysis]
90 Telarovic I, Wenger RH, Pruschy M. Interfering with Tumor Hypoxia for Radiotherapy Optimization. J Exp Clin Cancer Res 2021;40:197. [PMID: 34154610 DOI: 10.1186/s13046-021-02000-x] [Reference Citation Analysis]
91 de Souza ASC, Gonçalves LB, Lepique AP, de Araujo-Souza PS. The Role of Autophagy in Tumor Immunology-Complex Mechanisms That May Be Explored Therapeutically. Front Oncol 2020;10:603661. [PMID: 33335860 DOI: 10.3389/fonc.2020.603661] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
92 Mokoena DR, George BP, Abrahamse H. Photodynamic Therapy Induced Cell Death Mechanisms in Breast Cancer. Int J Mol Sci 2021;22:10506. [PMID: 34638847 DOI: 10.3390/ijms221910506] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Nandi A, Chakrabarti R. The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance. Genes Dev 2020;34:1422-38. [PMID: 33872192 DOI: 10.1101/gad.342287.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
94 Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct Target Ther 2022;7:258. [PMID: 35906199 DOI: 10.1038/s41392-022-01102-y] [Reference Citation Analysis]
95 Shi L, Duan R, Jia Q, Wu W, Zhou J, Li S, Zhang H, Xue X. Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer. Front Oncol 2022;12:871792. [DOI: 10.3389/fonc.2022.871792] [Reference Citation Analysis]
96 Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M. The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives. Int Immunopharmacol 2020;87:106807. [PMID: 32683299 DOI: 10.1016/j.intimp.2020.106807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
97 Cerbone L, Rebuzzi SE, Lattanzi E, Gnetti L, Iaia ML, D'Abbiero N, Buti S. Abscopal effect after hypofractionated radiotherapy in metastatic renal cell carcinoma pretreated with pazopanib. Immunotherapy 2020. [PMID: 32723023 DOI: 10.2217/imt-2020-0072] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Wang J, Saung MT, Li K, Fu J, Fujiwara K, Niu N, Muth S, Wang J, Xu Y, Rozich N, Zlomke H, Chen S, Espinoza B, Henderson M, Funes V, Herbst B, Ding D, Twyman-saint Victor C, Zhao Q, Narang A, He J, Zheng L. CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. Journal of Experimental Medicine 2022;219:e20211631. [DOI: 10.1084/jem.20211631] [Reference Citation Analysis]
99 Khan AR, Wei X, Xu X. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides. J Hepatocell Carcinoma 2021;8:1089-115. [PMID: 34522691 DOI: 10.2147/JHC.S318070] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Li Y, Li JQ, Jiang HP, Li X. The Upregulation of PLXDC2 Correlates with Immune Microenvironment Characteristics and Predicts Prognosis in Gastric Cancer. Dis Markers 2021;2021:5669635. [PMID: 34777633 DOI: 10.1155/2021/5669635] [Reference Citation Analysis]
101 Dey N, De P. Precision Medicine in Solid Tumors: How Far We Traveled So Far? Cancers 2022;14:3202. [DOI: 10.3390/cancers14133202] [Reference Citation Analysis]
102 Crezee T, Rabold K, de Jong L, Jaeger M, Netea-Maier RT. Metabolic programming of tumor associated macrophages in the context of cancer treatment. Ann Transl Med 2020;8:1028. [PMID: 32953828 DOI: 10.21037/atm-20-1114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Yang Z, Wu H, Zhang K, Rao S, Qi S, Liu M, Chen Y, Wang Y. Circ_0007580 knockdown strengthens the radiosensitivity of non-small cell lung cancer via the miR-598-dependent regulation of THBS2. Thorac Cancer 2022. [PMID: 35044104 DOI: 10.1111/1759-7714.14221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Jiang F, Miao XL, Zhang XT, Yan F, Mao Y, Wu CY, Zhou GP. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children. J Immunol Res 2021;2021:5523832. [PMID: 34337075 DOI: 10.1155/2021/5523832] [Reference Citation Analysis]
105 Zhao X, Shao C. Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade. Cancers (Basel) 2020;12:E2762. [PMID: 32992835 DOI: 10.3390/cancers12102762] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
106 Ma LR, Li JX, Tang L, Li RZ, Yang JS, Sun A, Leung EL, Yan PY. Immune checkpoints and immunotherapy in non-small cell lung cancer: Novel study progression, challenges and solutions. Oncol Lett 2021;22:787. [PMID: 34594428 DOI: 10.3892/ol.2021.13048] [Reference Citation Analysis]
107 Yan D, Zhao Q, Du Z, Li H, Geng R, Yang W, Zhang X, Cao J, Yi N, Zhou J, Tang Z. Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-10601-5] [Reference Citation Analysis]
108 Pinto B, Henriques AC, Silva PMA, Bousbaa H. Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research. Pharmaceutics. 2020;12. [PMID: 33291351 DOI: 10.3390/pharmaceutics12121186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
109 Ren X, Chen D, Wang Y, Li H, Zhang Y, Chen H, Li X, Huo M. Nanozymes-recent development and biomedical applications. J Nanobiotechnology 2022;20:92. [PMID: 35193573 DOI: 10.1186/s12951-022-01295-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
110 Guedes G, Wang S, Santos HA, Sousa FL. Polyoxometalate Composites in Cancer Therapy and Diagnostics: Polyoxometalate Composites in Cancer Therapy and Diagnostics. Eur J Inorg Chem 2020;2020:2121-32. [DOI: 10.1002/ejic.202000066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
111 Naz S, Leiker AJ, Choudhuri R, Preston O, Sowers AL, Gohain S, Gamson J, Mathias A, Van Waes C, Cook JA, Mitchell JB. Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis. Int J Radiat Oncol Biol Phys 2021;110:1295-305. [PMID: 33838214 DOI: 10.1016/j.ijrobp.2021.03.048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 León X, García J, Farré N, Majercakova K, Avilés-Jurado FX, Quer M, Camacho M. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy. Acta Otorrinolaringol Esp (Engl Ed) 2020:S0001-6519(20)30146-1. [PMID: 32972719 DOI: 10.1016/j.otorri.2020.05.003] [Reference Citation Analysis]
113 Ran J, Wang J, Dai Z, Miao Y, Gan J, Zhao C, Guan Q. Irradiation-Induced Changes in the Immunogenicity of Lung Cancer Cell Lines: Based on Comparison of X-rays and Carbon Ions. Front Public Health 2021;9:666282. [PMID: 33968889 DOI: 10.3389/fpubh.2021.666282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Jarosz-Biej M, Smolarczyk R, Cichoń T, Drzyzga A, Czapla J, Urbaś Z, Pilny E, Matuszczak S, Wojcieszek P. Brachytherapy in a Single Dose of 10Gy as an "in situ" Vaccination. Int J Mol Sci 2020;21:E4585. [PMID: 32605154 DOI: 10.3390/ijms21134585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Swamy K. Stereotactic Body Radiotherapy Immunological Planning-A Review With a Proposed Theoretical Model. Front Oncol 2022;12:729250. [PMID: 35155221 DOI: 10.3389/fonc.2022.729250] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Song CW, Kim H, Cho H, Kim M, Paek S, Park H, Griffin RJ, Terezakis S, Cho LC. HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR). Cancers 2022;14:3273. [DOI: 10.3390/cancers14133273] [Reference Citation Analysis]